Table 2. Results for the five loci associated (p<5.0×10−8) with retinal venular caliber in the discovery cohorts both combined and individually.
Discovery cohorts combined | Discovery cohorts individually | ||||||||||||||||||
CHARGE | AGES | ARIC | CHS | RS | |||||||||||||||
SNP (chromosome position) locus | Minor allele (MAF) | Beta | SE | P-value | Beta | SE | P-value | Beta | SE | P-value | Beta | SE | P-value | Beta | SE | P-value | Genes of Interest | Other genes within 60kb | Additional SNPs at p-value<5×10−8 |
rs2287921 (53920084)19q13 | T (0.47) | −2.0 | 0.23 | 3.30×10−18 | −1.0 | 0.56 | 7.40×10−2 | −2.5 | 0.36 | 3.80×10−12 | −2.9 | 0.77 | 1.66×10−4 | −1.7 | 0.42 | 5.17×10−5 | RASIP1 | IZUMO1, FUT1 FUT2, CA11 FGF21, FLJ36070 | 37 |
rs225717 (142589792)6q24 | C (0.23) | −1.8 | 0.27 | 5.99×10−12 | −1.9 | 0.60 | 1.54×10−3 | −2.2 | 0.40 | 7.25×10−8 | −2.0 | 0.96 | 3.70×10−2 | −1.3 | 0.50 | 9.32×10−3 | VTA1 | NMBR | 31 |
rs10774625 (110394602)12q24 | A (0.48) | 1.6 | 0.23 | 1.16×10−11 | 1.3 | 0.43 | 2.50×10−3 | 1.5 | 0.35 | 1.82×10−5 | 1.9 | 0.75 | 1.10×10−2 | 1.7 | 0.43 | 7.70×10−5 | ATXN2 | SH2B3, PTPN11 | 9 |
rs17421627 (87883342)5q14 | G (0.08) | 2.5 | 0.43 | 5.05×10−9 | 2.2 | 1.16 | 5.80×10−2 | 1.6 | 0.63 | 1.10×10−2 | 5.3 | 1.91 | 5.52×10−3 | 3.2 | 0.71 | 6.57×10−6 | - | MEF2C | 28 |
rs7824557 (11141521)8p23 | G (0.39) | 1.4 | 0.23 | 2.17×10−9 | 1.6 | 0.56 | 4.27×10−3 | 0.8 | 0.35 | 2.2×10−2 | 1.7 | 0.84 | 4.30×10−2 | 2.2 | 0.43 | 5.32×10−7 | - | XKR6, PINX1 SOX7, MTMR9 GATA4 | 69 |
CHARGE: Cohorts for Heart and Aging Research in Genomic Epidemiology consortium; AGES: Age Gene/Environment Susceptibility – Reykjavik Study; ARIC: Atherosclerosis Risk in Communities Study; CHS: Cardiovascular Health Study; RS: Rotterdam Study; SNP: single nucleotide polymorphism; MAF: minor allele frequency; Beta: Change in retinal venular calibre for each copy of the minor allele; SE: standard error.